Login
$VXRT
$0.32 +$0.00 (0.0%) Close

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age 2024 pay Source
Steven Lo Also a director
President, Chief Exec Officer
Title from the Form 4 dated Mar 24, 2026
58 $2,085,768
Jeroen Grasman
Chief Financial Officer
Title from the Form 4 dated May 19, 2026
Not stated Not reported
James F. Cummings
Chief Medical Officer
Title from the Form 4 dated Mar 28, 2026
Not stated $1,212,535
Sean Tucker
SVP, Chief Scientific Officer
Title from the Form 4 dated Mar 28, 2026
Not stated $1,155,031
Edward B Berg
SVP, General Counsel
Title from the Form 4 dated Mar 24, 2026
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 10, 2025 · updated by the 8-Ks of Sep 2, 2025, Apr 23, 2026, and Oct 19, 2026

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
2.2 years
from year joined
Director Age On board Independent Committees Other public boards 2024 pay Source
Steven Lo
58 2024
1 year
Not independent None stated None stated Paid as CEO
Kevin P. Finney
57 2025
this year
Independent
Audit Committee
None stated Not stated
Elaine J. Heron, Ph.D.
77 2022
3 years
Independent
Compensation Committee
BioMarin Pharmaceutical Inc. $143,779
W. Mark Watson
74 2022
3 years
Independent
Audit Committee · Chair
None stated $142,881
David Wheadon, M.D.
67 2021
4 years
Independent None stated None stated $146,976
James B. Breitmeyer Joined Apr 23, 2026
- - Independent - - -
Raquel C. Bono Joined Oct 19, 2026
- - Independent - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

3 disclosed in the proxy filed Apr 10, 2025
executive officers and directors
executive officers and directors of the Company
Amount not stated

Indemnity agreements under which the Company will indemnify and advance expenses to executive officers and directors.

Mr. Floroiu
former President and Chief Executive Officer
Amount not stated

Separation Agreement entered into on January 31, 2024 with the former President and Chief Executive Officer.

executive officers and members of our board of directors
executive officers and members of our board of directors
Amount not stated

Grants of stock options to executive officers and board members.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support